PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF SELADELPAR IN SUBJECTS WITH HEPATIC IMPAIRMENT

Category Primary study
JournalGastroenterology
Year 2019
This article has no abstract
Epistemonikos ID: 93cb5e5660028e9c1eebc518f7dd31b879583385
First added on: Feb 10, 2025